These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8368634)

  • 1. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
    Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [KL-6 in patients with interstitial pneumonitis].
    Hamada H; Sakatani M; Ueda E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Kunitake R; Kuwano K; Yoshida K; Maeyama T; Kawasaki M; Hagimoto N; Hara N
    Respiration; 2001; 68(5):488-95. PubMed ID: 11694811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.
    Inoue Y; Barker E; Daniloff E; Kohno N; Hiwada K; Newman LS
    Am J Respir Crit Care Med; 1997 Jul; 156(1):109-15. PubMed ID: 9230733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of serum KL-6 levels in summer-type hypersensitivity pneumonitis].
    Nakajima M; Toshiaki M; Yoshida K; Niki Y; Matsushima T
    Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):763-70. PubMed ID: 9866978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases.
    Wattiez R; Hermans C; Cruyt C; Bernard A; Falmagne P
    Electrophoresis; 2000 Jul; 21(13):2703-12. PubMed ID: 10949149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
    Specks U; Martin WJ; Rohrbach MS
    Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lung injury animal model using KL-6-measurable human MUC1-expressing mice.
    Sakai M; Kubota T; Ohnishi H; Yokoyama A
    Biochem Biophys Res Commun; 2013 Mar; 432(3):460-5. PubMed ID: 23410752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy.
    Tokiya R; Hiratsuka J; Yoshida K; Imai S; Kajihara Y; Imajo Y
    Int J Clin Oncol; 2004 Dec; 9(6):498-502. PubMed ID: 15616881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
    Meyer KC; Cardoni A; Xiang ZZ
    J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis.
    Reynolds SP; Jones KP; Edwards JH; Davies BH
    Sarcoidosis; 1989 Sep; 6(2):125-34. PubMed ID: 2602684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.